PL2021358T3 - Modyfikowane bakteriocyny i sposoby ich stosowania - Google Patents
Modyfikowane bakteriocyny i sposoby ich stosowaniaInfo
- Publication number
- PL2021358T3 PL2021358T3 PL07797461T PL07797461T PL2021358T3 PL 2021358 T3 PL2021358 T3 PL 2021358T3 PL 07797461 T PL07797461 T PL 07797461T PL 07797461 T PL07797461 T PL 07797461T PL 2021358 T3 PL2021358 T3 PL 2021358T3
- Authority
- PL
- Poland
- Prior art keywords
- bacteriocins
- modified
- methods
- bacteria
- receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74729906P | 2006-05-15 | 2006-05-15 | |
PCT/US2007/068908 WO2007134303A2 (en) | 2006-05-15 | 2007-05-14 | Modified bacteriocins and methods for their use |
EP07797461A EP2021358B1 (en) | 2006-05-15 | 2007-05-14 | Modified bacteriocins and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2021358T3 true PL2021358T3 (pl) | 2012-09-28 |
Family
ID=38694773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07797461T PL2021358T3 (pl) | 2006-05-15 | 2007-05-14 | Modyfikowane bakteriocyny i sposoby ich stosowania |
Country Status (11)
Country | Link |
---|---|
US (1) | US7732586B2 (pl) |
EP (2) | EP2371842B1 (pl) |
JP (1) | JP5603070B2 (pl) |
AT (1) | ATE551354T1 (pl) |
AU (1) | AU2007249199B2 (pl) |
BR (1) | BRPI0711969A2 (pl) |
CA (1) | CA2652450C (pl) |
DK (2) | DK2371842T3 (pl) |
ES (2) | ES2548392T3 (pl) |
PL (1) | PL2021358T3 (pl) |
WO (1) | WO2007134303A2 (pl) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006307018B2 (en) * | 2005-10-28 | 2012-10-25 | Meiji Seika Kaisha, Ltd. | Outer coat protein PA5158 of Pseudomonas aeruginosa |
US8445639B2 (en) | 2006-05-15 | 2013-05-21 | Avidbiotics Corporation | Recombinant bacteriophage and methods for their use |
US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
JP5781762B2 (ja) * | 2007-08-10 | 2015-09-24 | プロテリックス、インク | ユニバーサルiii型フィブロネクチン結合ドメインのライブラリ |
US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
US20110021414A1 (en) * | 2007-10-24 | 2011-01-27 | Texas A & M University System | Chimeric Phage Tail Proteins and Uses Thereof |
US9115354B2 (en) | 2010-05-27 | 2015-08-25 | Avidbiotics Corp. | Diffocins and methods of use thereof |
KR101955171B1 (ko) | 2010-05-27 | 2019-03-06 | 사이포스 바이오사이언시스 인코포레이티드 | 디포신 및 그의 사용 방법 |
EP2576811A1 (en) | 2010-06-02 | 2013-04-10 | Johns Hopkins University | System and methods for determining drug resistance in microorganisms |
WO2015022306A1 (en) | 2013-08-12 | 2015-02-19 | Dupont Nutrition Biosciences Aps | Methods for classification of microorganisms from food products |
GB201416788D0 (en) * | 2014-09-23 | 2014-11-05 | Univ Glasgow | Therapeutic applications for pyocins |
AU2015342937B2 (en) * | 2014-11-07 | 2019-06-06 | Pylum Biosciences, Inc. | Monocins and methods of use |
WO2019014061A1 (en) * | 2017-07-12 | 2019-01-17 | Dow Global Technologies, Llc | COMPOSITIONS AND METHODS FOR REMOVAL OF SULFATOR EDUCING PROKARYOTES |
US11572595B2 (en) | 2018-12-31 | 2023-02-07 | Roche Molecular Systems, Inc. | Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems |
CN110129279B (zh) * | 2019-04-24 | 2022-02-18 | 昆明理工大学 | 一种粪肠球菌噬菌体及其分离、纯化、富集和应用 |
CA3178705A1 (en) * | 2020-04-07 | 2021-10-14 | Pylum Biosciences, Inc. | Enterocins and methods of using the same |
CN112083253B (zh) * | 2020-09-18 | 2021-07-02 | 西南交通大学 | 一种直流下土壤电参量状态反演方法 |
WO2023178352A2 (en) * | 2022-03-18 | 2023-09-21 | Carnegie Mellon University | Lysin and gp38 peptides for bacteria detection |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4142939A (en) | 1976-03-31 | 1979-03-06 | Oregon State Board Of Higher Education, An Agency Of The State Of Oregon | Method of producing an r-type bacteriocin and its use in the detection of specific microorganisms |
US4861754A (en) | 1986-05-28 | 1989-08-29 | Farkas Himsley Hannah | Bacteriocins and compositions thereof in anti-viral treatment |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
US6355411B1 (en) | 1997-11-25 | 2002-03-12 | The General Hospital Corporation | Virulence-associated nucleic acid sequences and uses thereof |
US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
AU4499499A (en) | 1999-04-01 | 2000-10-23 | Innogenetics N.V. | A polypeptide structure for use as a scaffold |
WO2001001786A2 (en) * | 1999-07-06 | 2001-01-11 | Friesland Brands B.V. | Methods and means for producing improved dairy products |
US7034113B2 (en) * | 2002-02-22 | 2006-04-25 | Paradigm Diagnostics, Llc | Bacteriocin-metal complexes in the detection of pathogens and other biological analytes |
CA2541941C (en) | 2003-10-06 | 2015-05-26 | Gangagen, Inc. | Anti-bacterial phage tail compositions and uses thereof |
CN101090967A (zh) | 2004-08-03 | 2007-12-19 | 加利福尼亚大学董事会 | 产多形性蛋白质序列的位点特异性系统 |
US20060229244A1 (en) | 2004-09-27 | 2006-10-12 | Robert Dorit | Engineered bacteriocins and bacteriocin combinations and methods for treating bacterial based infections |
-
2007
- 2007-05-14 DK DK11154069.6T patent/DK2371842T3/en active
- 2007-05-14 EP EP11154069.6A patent/EP2371842B1/en active Active
- 2007-05-14 CA CA2652450A patent/CA2652450C/en active Active
- 2007-05-14 JP JP2009511196A patent/JP5603070B2/ja active Active
- 2007-05-14 ES ES11154069.6T patent/ES2548392T3/es active Active
- 2007-05-14 EP EP07797461A patent/EP2021358B1/en active Active
- 2007-05-14 DK DK07797461.6T patent/DK2021358T3/da active
- 2007-05-14 AT AT07797461T patent/ATE551354T1/de active
- 2007-05-14 BR BRPI0711969-0A patent/BRPI0711969A2/pt not_active Application Discontinuation
- 2007-05-14 ES ES07797461T patent/ES2387722T3/es active Active
- 2007-05-14 WO PCT/US2007/068908 patent/WO2007134303A2/en active Search and Examination
- 2007-05-14 US US11/748,432 patent/US7732586B2/en active Active
- 2007-05-14 PL PL07797461T patent/PL2021358T3/pl unknown
- 2007-05-14 AU AU2007249199A patent/AU2007249199B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
DK2371842T3 (en) | 2015-10-26 |
BRPI0711969A2 (pt) | 2012-01-24 |
US7732586B2 (en) | 2010-06-08 |
AU2007249199B2 (en) | 2012-02-09 |
WO2007134303A2 (en) | 2007-11-22 |
EP2021358B1 (en) | 2012-03-28 |
ES2387722T3 (es) | 2012-09-28 |
ES2548392T3 (es) | 2015-10-16 |
EP2371842B1 (en) | 2015-07-22 |
EP2021358A2 (en) | 2009-02-11 |
US20080113406A1 (en) | 2008-05-15 |
JP5603070B2 (ja) | 2014-10-08 |
JP2009537146A (ja) | 2009-10-29 |
DK2021358T3 (da) | 2012-07-16 |
AU2007249199A1 (en) | 2007-11-22 |
WO2007134303A3 (en) | 2008-03-13 |
CA2652450C (en) | 2013-10-15 |
EP2371842A1 (en) | 2011-10-05 |
CA2652450A1 (en) | 2007-11-22 |
ATE551354T1 (de) | 2012-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2021358T3 (pl) | Modyfikowane bakteriocyny i sposoby ich stosowania | |
CY2018013I2 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
MY156458A (en) | Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof | |
WO2006085938A3 (en) | Il-13 binding agents | |
HK1210724A1 (en) | Interleukin-13 antibody composition 13 | |
WO2011039510A3 (en) | Conjugates targeting the cd163 receptor | |
EP1809326A4 (en) | MODULATION OF ANTIBODY SPECIFICITY BY MEASURING ADAPTATION OF ITS AFFINITY TO AN APPARENT ANTIGEN | |
MA30153B1 (fr) | Anticorps anti-ox40l et methodes correspondantes | |
HRP20130400T1 (en) | Anti-il-23 antibodies, compositions, methods and uses | |
WO2009035528A3 (en) | Synthetic lipid a derivative | |
BR112013011193A2 (pt) | bacteriófago p4 recombinante e métodos para seu uso | |
ZA200711073B (en) | Anti-MCP-1 antibodies, compositions, methods and uses | |
EP2362862A4 (en) | MODIFIED SULFUR BINDING AGENT AND METHOD OF PRODUCTION THEREOF, COMPOSITION COMPRISING HYDRAULIC MODIFIED SULFUR COMPOSITION, AND METHOD OF PREPARING THEREOF OR COMBUSTIBLE MODIFIED SULFUR COMPOSITION, AND PRODUCTION PROCESS THEREOF, CONTAINING THE MODIFIED SULFUR BINDING AGENT | |
IL206036A0 (en) | ANTIBODIES TO THE PcrV ANTIGEN OF PSEUDOMONAS AERUGINOSA AND USES THEREOF | |
WO2008150530A3 (en) | Cripto binding molecules | |
JP2008542528A5 (pl) | ||
WO2009055074A8 (en) | Erbb2 binding proteins and use thereof | |
WO2007030761A3 (en) | Acyclic 1,4-diamines and uses thereof | |
EP1934318A4 (en) | TRACTION FLUID COMPOSITION | |
WO2007144778A3 (en) | Herbal compositions for the prevention or treatment of a urinary tract infection | |
EP1860182A4 (en) | METHOD FOR REGENERATING ELASTIC FIBERS USING DANCE OR AN IMPROVING FACTOR THEREOF | |
WO2009047462A9 (fr) | Feuille de verre silico-sodo-calcique | |
EP1957629A4 (en) | Multi-analyte affinity column | |
WO2006041808A3 (en) | Tafi inhibitors and their use to treat pulmonary fibrosis | |
WO2009106258A8 (de) | Herbizid-kombinationen enthaltend diflufenican |